Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy have?
Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy has 277 citations in the OpenAlex counts ScholarIQ stores.
When was Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy published?
Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy has 2016 year in the ScholarIQ index.
What is the open-access status of Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy?
Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy has closed oa status in the ScholarIQ index.
What is the DOI of Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy?
The DOI for Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy is on the source record.
What is the PMID of Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy?
The PMID for Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy is on the source record.
What is the OpenAlex record for Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy?
The OpenAlex for Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy is on the source record.